Dean, College of Engineering, University of Michigan
Executive VP of R&D, Biogen Idec
President, Merck Research Laboratories
General Partner, Flybridge Capital Partners
Professor, Stanford University
Senior Partner, Bessemer Venture Partners
CEO, TrustPlus
President, University of Texas MD Anderson Cancer Center
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs | Luke Timmerman | 02/28/13 | Boston | |
| Lux Bio Resurfaces With Defined Path for Pill for Rare Eye Disease | Arlene Weintraub | 07/09/12 | New York | |
| Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund | Luke Timmerman | 10/17/11 | San Francisco | |
| Page 1 of 1 | ||||